Liver Disease
From the Journals
Novel capsid assembly modulator shows promise in HBV
However, one patient developed severe rash soon after completing treatment.
From the AGA Journals
AGA Clinical Practice Update: Surgical risk assessment and perioperative management in cirrhosis
Patients with cirrhosis should be risk stratified and counseled accordingly before all but the most urgent surgeries, cautions a clinical practice...
Conference Coverage
Ultrasound method predicts liver complications in pediatric transplant
HOUSTON – Using shear wave elastography predicted disease at least 4 days before standard diagnostic criteria in most patients.
From the Journals
HCV-infected patients in the ED should be tested for advanced liver fibrosis
From the Journals
DAAs reduce mortality, cancer risk in HCV study
Large, prospective study showed direct-acting antivirals reduced mortality and cancer risk in chronic HCV-infected patients.
From the Journals
NASH: Fastest-growing cause of liver cancer in transplant candidates
Its prevalence rose nearly 700% between 2002 and 2017.
From the Journals
Residential HCV program improves veterans’ diagnosis and care
Conference Coverage
mRECIST response to kinase inhibitors predicts survival in HCC
SAN FRANCISCO – Among patients with untreated HCC given first-line kinase inhibitors, those having a response based on mRECIST criteria lived...
From the Journals
HBV, HCV, HIV testing of new cancer patients advised
Many patients with newly diagnosed cancers were unaware of their infection status, and some had no known risk factors.
From the Journals
Perceptions of liver transplantation for ALD are evolving
Liver transplantation for alcohol-associated liver disease is occurring earlier and more frequently than before.